5-(5-溴戊基)-3-甲基异恶唑 | 98033-85-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-(5-溴戊基)-3-甲基异恶唑
• 英文名称: 5-(5-bromopentyl)-3-methylisoxazole
• 英文别名: 5-(5-bromopentyl)-3-methyl-1,2-oxazole
• CAS: 98033-85-3
• 化学式: C₉H₁₄BrNO
• 分子量: 232.12
• InChiKey: GOJOHHBMSHTFRG-UHFFFAOYSA-N

物化性质

• 沸点：
  307.7±30.0 °C(Predicted)
• 密度：
  1.309±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  26
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(5-溴戊基)-3-甲基异恶唑 在 Amberlyst A-26 (carbonate form) 作用下， 以 苯 为溶剂， 反应 4.0h， 以57%的产率得到5-(3-甲基-1,2-恶唑-5-基)-1-戊醇
  参考文献：
  名称：

  一些二取代的苯基异恶唑类抗人小核糖核酸病毒的合成及结构活性研究。

  摘要：

  已经制备了广谱抗小核糖核酸病毒药物二恶草腈的许多2，6-二取代类似物，并针对几种鼻病毒血清型进行了评估。QSAR的一项研究表明，针对五种鼻病毒血清型的平均MIC（MIC）与log P密切相关。2,6-二氯类似物15在体外对MIC80为0.3 microM的鼻病毒非常有效，对几种肠病毒，并且在预防感染柯萨奇A-9的小鼠中也有效地预防了麻痹。

  DOI：

  10.1021/jm00122a027
• 作为产物：
  描述：

  3,5-二甲基异唑 、 1,4-二溴丁烷 在 正丁基锂 、 二异丙胺 作用下， 生成 5-(5-溴戊基)-3-甲基异恶唑
  参考文献：
  名称：

  [[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating

  摘要：

  A series of [[(4,5-dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles has been synthesized and evaluated as antipicornavirus agents. The effect of alkyl groups in the 4- and 5-position of the oxazoline ring, as well as the alkyl chain length, on antiviral activity was examined. Compound 14 was evaluated in vivo and was found to significantly reduce mortality at an oral dose of 4 mg/kg in mice infected intracerebrally with poliovirus-2. Compound 14 was also effective in preventing paralysis when administered intraperitoneally to mice infected subcutaneously with a lethal dose of ECHO-9 virus. On the basis of the results of these studies, compound 14 is a strong candidate for clinical evaluation as a systemic agent for the treatment of picornavirus infections.

  DOI：

  10.1021/jm00150a025
• 作为试剂：
  描述：

  5-(5-溴戊基)-3-甲基异恶唑 、 2,6-Dichloro-4-(4,5-dihydro-2-oxazolyl)phenol 在 5-(5-溴戊基)-3-甲基异恶唑 作用下， 生成 5-{5-[2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy]pentyl}-3-methylisoxazole
  参考文献：
  名称：

  J. Med. Chem. 1989, 32, 450-455

  摘要：

  DOI：

文献信息

• Heterocyclic substituted-phenoxyalkylisoxazoles as antiviral useful
  申请人：Sterling Drug Inc.

  公开号：US04857539A1

  公开（公告）日：1989-08-15

  Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms; Z is N or HC; R is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when Z is N, R is lower-alkyl; R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and Het is selected from specified heterocyclic groups, are useful and antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.

  化合物的公式为##STR1##其中：Y是3-9个碳原子的烷基桥；Z是N或HC；R是氢或1-5个碳原子的低烷基，但当Z是N时，R是低烷基；R.sub.1和R.sub.2是氢、卤素、低烷基、低烷氧基、硝基、低烷氧羰基或三氟甲基；Het从指定的杂环基团中选择，对抗病毒剂，特别是对抗小RNA病毒，包括多种鼻病毒菌株。
• Di-heterocyclic compounds and their use as antiviral agents
  申请人：Sterling Drug Inc.

  公开号：US04843087A1

  公开（公告）日：1989-06-27

  Compounds of the formulas: ##STR1## wherein Het is an oxazole or oxazine moiety; X is O, S or SO, n is an integer from 3 to 9, Y is an aliphatic bridge; and the various R groups represent hydrogen or various substituents as described herein, are useful as antiviral agents, especially against picornaviruses. N-(Chloroalkyl)amide intermediates for the compounds of Formula I are also active as antiviral agents. Related compounds outside the scope of the above formulas are also disclosed.

  公式化合物：##STR1## 其中Het是噁唑或噁唑啉基团；X是O、S或SO，n是从3到9的整数，Y是脂肪桥；各种R基团代表氢或如本文所述的各种取代基，可用作抗病毒剂，特别是对抗小RNA病毒。用于公式I化合物的N-(氯烷基)酰胺中间体也作为抗病毒剂活性。还披露了超出上述公式范围的相关化合物。
• Structure-activity studies of 5-[[4-(4,5-dihydro-2-oxazolyl)phenoxy]alkyl]-3-methylisoxazoles: inhibitors of picornavirus uncoating
  作者：Guy D. Diana、Richard C. Oglesby、Vahan Akullian、Philip M. Carabateas、David Cutcliffe、John P. Mallamo、Michael J. Otto、Mark A. McKinlay、Edward G. Maliski、Stephen J. Michalec

  DOI：10.1021/jm00385a021

  日期：1987.2

  A series of substituted phenyl analogues of 5-[[4-(4,5-dihydro-2-oxazolyl) phenoxy]alkyl]-3-methylisoxazoles has been synthesized and evaluated in vitro against several human rhinovirus (HRV) serotypes. Substituents in the 2-position greatly enhanced activity when compared to the unsubstituted compound. Many of these compounds exhibited mean MICs (MIC) against five serotypes as low as 0.40 microM.

  已经合成了一系列5-[[[4-（4,5-二氢-2-恶唑基）苯氧基]烷基] -3-甲基异恶唑的取代苯基类似物，并在体外针对几种人鼻病毒（HRV）血清型进行了评估。与未取代的化合物相比，位于2位的取代基大大提高了活性。这些化合物中的许多都表现出针对低至0.40 microM的五种血清型的平均MIC（MIC）。平均MIC与MIC80（抑制80％所测试血清型的浓度）相关性很好（r = 0.83）。定量结构-活性关系研究表明，MIC与亲脂性（log P）以及诱导效应（sigma m）和体积因子（MW）密切相关。
• 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral
  申请人：Sterling Drug Inc.

  公开号：US05175178A1

  公开（公告）日：1992-12-29

  Compounds of the formulas ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms; R' is lower-alkyl or hydroxy-lower-alkyl of 1-5 carbon atoms; R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and R.sub.8 is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when R.sub.8 is hydrogen R' is hydroxy-lower-alkyl, are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.

  化学式为##STR1##的化合物，其中：Y是3-9个碳原子的烷基桥；R'为1-5个碳原子的低碳基或羟基低碳基；R.sub.1和R.sub.2为氢、卤素、低碳基、低碳氧基、硝基、低碳氧羰基或三氟甲基；R.sub.8为氢或1-5个碳原子的低碳基，但当R.sub.8为氢时，R'为羟基低碳基。这些化合物可用作抗病毒剂，特别是对抗多种鼻病毒菌株，包括脊髓灰质炎病毒。
• 1,3,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral
  申请人：Sterling Drug Inc.

  公开号：US05110821A1

  公开（公告）日：1992-05-05

  Compounds of the formula ##STR1## wherein: Y is an alkylene bridge of 3-9 carbon atoms; R' is lower-alkyl or hydroxy-lower-alkyl or 1-5 carbon atoms; R.sub.1 and R.sub.2 are hydrogen, halogen, lower-alkyl, lower-alkoxy, nitro, lower-alkoxycarbonyl or trifluoromethyl; and R.sub.8 is hydrogen or lower-alkyl of 1-5 carbon atoms, with the proviso that when R.sub.8 is hydrogen R' is hydroxy-lower-alkyl, are useful as antiviral agents, particularly against picornaviruses, including numerous strains of rhinovirus.

  分子式为##STR1##的化合物，其中：Y是3-9个碳原子的烷基桥；R'是低级烷基或羟基-低级烷基或1-5个碳原子；R.sub.1和R.sub.2是氢、卤素、低级烷基、低级烷氧基、硝基、低级烷氧羰基或三氟甲基；R.sub.8是氢或1-5个碳原子的低级烷基，但当R.sub.8是氢时，R'为羟基-低级烷基，可用作抗病毒剂，特别是对抗小肠病毒，包括大量的鼻病毒菌株。